Britain to research on Ashwagandha which proved to be effective for coronavirus patients

Indian scientists brag about modern medical science and consider Ayurvedic Science inferior, while Britain is trying to research Ayurvedic medicine and use it for their citizens.

New Delhi – In India, after a study it was found that the coronavirus patients benefited from the Ayurvedic medication made from Ashwagandha. After its success in India, this medication will be studied for the first time outside India. For this research, an agreement was signed between India and Britain.

कोविड-19 से उबरने में अश्वगंधा के लाभों पर भारत, ब्रिटेन मिलकर करेंगे अध्ययनhttps://t.co/2PqbdByFol

— रिपब्लिक.भारत (@Republic_Bharat) August 1, 2021

After 16 months and more than 100 meetings, the All India Institute of Ayurveda (AIIA), an autonomous body under the Ministry of Ayush and The London School of Hygiene and Tropical Medicine has decided to inspect and treat the coronavirus patients in three cities. Director of ‘Akhil Bharatiya Ayurvedic Sanstha’ and Project Coordinator Dr. Tanuja Manoj Nesari said that ‘In the coming 90-days, a study will be conducted on coronavirus patients in Leicester, Birmingham, and London.

After that comparative study will be done for the next 90-days. Ashwagandha has shown good results in India. Ashwagandha has shown positive results in long-term Covid symptoms and can be used as a good option to nullify long-term Covid symptoms.